154 related articles for article (PubMed ID: 28234785)
1. Noninvasive detection of matrix metalloproteinase-9 in atherosclerotic lesions using technetium-99m-labeled single-photon emission computed tomography in vivo.
Wang Z; Deng G; Zhang Z; Huang H; Zhao Y
Nucl Med Commun; 2017 Apr; 38(4):299-305. PubMed ID: 28234785
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.
Fujimoto S; Hartung D; Ohshima S; Edwards DS; Zhou J; Yalamanchili P; Azure M; Fujimoto A; Isobe S; Matsumoto Y; Boersma H; Wong N; Yamazaki J; Narula N; Petrov A; Narula J
J Am Coll Cardiol; 2008 Dec; 52(23):1847-1857. PubMed ID: 19038682
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor.
Ohshima S; Petrov A; Fujimoto S; Zhou J; Azure M; Edwards DS; Murohara T; Narula N; Tsimikas S; Narula J
J Nucl Med; 2009 Apr; 50(4):612-7. PubMed ID: 19289429
[TBL] [Abstract][Full Text] [Related]
4. In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.
Dimastromatteo J; Broisat A; Perret P; Ahmadi M; Boturyn D; Dumy P; Fagret D; Riou LM; Ghezzi C
J Nucl Med; 2013 Aug; 54(8):1442-9. PubMed ID: 23719858
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice.
Broisat A; Toczek J; Dumas LS; Ahmadi M; Bacot S; Perret P; Slimani L; Barone-Rochette G; Soubies A; Devoogdt N; Lahoutte T; Fagret D; Riou LM; Ghezzi C
J Nucl Med; 2014 Oct; 55(10):1678-84. PubMed ID: 25157043
[TBL] [Abstract][Full Text] [Related]
6. Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis.
Dietrich T; Berndorff D; Heinrich T; Hucko T; Stepina E; Hauff P; Dinkelborg LM; Atrott K; Giovannoni L; Neri D; Fleck E; Graf K; Menssen HD
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):228-37. PubMed ID: 25864530
[TBL] [Abstract][Full Text] [Related]
7. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.
Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X
Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307
[TBL] [Abstract][Full Text] [Related]
8. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.
Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM
Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of activated matrix metalloproteinases in vascular remodeling.
Zhang J; Nie L; Razavian M; Ahmed M; Dobrucki LW; Asadi A; Edwards DS; Azure M; Sinusas AJ; Sadeghi MM
Circulation; 2008 Nov; 118(19):1953-60. PubMed ID: 18936327
[TBL] [Abstract][Full Text] [Related]
10. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo.
Schäfers M; Riemann B; Kopka K; Breyholz HJ; Wagner S; Schäfers KP; Law MP; Schober O; Levkau B
Circulation; 2004 Jun; 109(21):2554-9. PubMed ID: 15123523
[TBL] [Abstract][Full Text] [Related]
11. A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes.
Tekabe Y; Luma J; Einstein AJ; Sedlar M; Li Q; Schmidt AM; Johnson LL
J Nucl Med; 2010 Jan; 51(1):92-7. PubMed ID: 20008983
[TBL] [Abstract][Full Text] [Related]
12. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
Mol Imaging; 2014; 13():. PubMed ID: 24757762
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of [
Kiugel M; Hellberg S; Käkelä M; Liljenbäck H; Saanijoki T; Li XG; Tuomela J; Knuuti J; Saraste A; Roivainen A
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513758
[No Abstract] [Full Text] [Related]
15. Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm.
Toczek J; Ye Y; Gona K; Kim HY; Han J; Razavian M; Golestani R; Zhang J; Wu TL; Jung JJ; Sadeghi MM
J Nucl Med; 2017 Aug; 58(8):1318-1323. PubMed ID: 28360209
[TBL] [Abstract][Full Text] [Related]
16. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
Ayala-López W; Xia W; Varghese B; Low PS
J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
[TBL] [Abstract][Full Text] [Related]
17. Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers.
Khaw BA; Tekabe Y; Johnson LL
J Nucl Med; 2006 May; 47(5):868-76. PubMed ID: 16644758
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5.
Isobe S; Tsimikas S; Zhou J; Fujimoto S; Sarai M; Branks MJ; Fujimoto A; Hofstra L; Reutelingsperger CP; Murohara T; Virmani R; Kolodgie FD; Narula N; Petrov A; Narula J
J Nucl Med; 2006 Sep; 47(9):1497-505. PubMed ID: 16954559
[TBL] [Abstract][Full Text] [Related]
19. Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.
Broisat A; Hernot S; Toczek J; De Vos J; Riou LM; Martin S; Ahmadi M; Thielens N; Wernery U; Caveliers V; Muyldermans S; Lahoutte T; Fagret D; Ghezzi C; Devoogdt N
Circ Res; 2012 Mar; 110(7):927-37. PubMed ID: 22461363
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Antiatherogenic Properties of Ezetimibe Using
Dumas LS; Briand F; Clerc R; Brousseau E; Montemagno C; Ahmadi M; Bacot S; Soubies A; Perret P; Riou LM; Devoogdt N; Lahoutte T; Barone-Rochette G; Fagret D; Ghezzi C; Sulpice T; Broisat A
J Nucl Med; 2017 Jul; 58(7):1088-1093. PubMed ID: 28280218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
